Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
  • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
  • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
  • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
  • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
  • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K38/00—Medicinal preparations containing peptides
  • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
  • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
  • A61K38/36—Blood coagulation or fibrinolysis factors
  • A61K38/37—Factors VIII
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K39/00—Medicinal preparations containing antigens or antibodies
  • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
  • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
  • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
  • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01D—SEPARATION
  • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
  • B01D61/02—Reverse osmosis; Hyperfiltration ; Nanofiltration
  • B01D61/025—Reverse osmosis; Hyperfiltration
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K39/00—Medicinal preparations containing antigens or antibodies
  • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01D—SEPARATION
  • B01D2315/00—Details relating to the membrane module operation
  • B01D2315/10—Cross-flow filtration
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01D—SEPARATION
  • B01D2315/00—Details relating to the membrane module operation
  • B01D2315/16—Diafiltration

Landscapes

• Health & Medical Sciences (AREA)
• Chemical & Material Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Engineering & Computer Science (AREA)
• Medicinal Chemistry (AREA)
• Animal Behavior & Ethology (AREA)
• Veterinary Medicine (AREA)
• Public Health (AREA)
• General Health & Medical Sciences (AREA)
• Pharmacology & Pharmacy (AREA)
• Epidemiology (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Water Supply & Treatment (AREA)
• Immunology (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Zoology (AREA)
• Hematology (AREA)
• Proteomics, Peptides & Aminoacids (AREA)
• Gastroenterology & Hepatology (AREA)
• Nanotechnology (AREA)
• Oil, Petroleum & Natural Gas (AREA)
• Microbiology (AREA)
• General Chemical & Material Sciences (AREA)
• Mycology (AREA)
• Peptides Or Proteins (AREA)
• Medicinal Preparation (AREA)
• Preparation Of Compounds By Using Micro-Organisms (AREA)
• Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
• Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
• Saccharide Compounds (AREA)
• Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Applications Claiming Priority (3)

Publications (1)

Family

ID=44483343

Family Applications (1)

Country Status (34)

Families Citing this family (7)

Family Cites Families (10)

• 2011
  • 2011-02-21 EA EA201290804A patent/EA201290804A1/ru unknown
  • 2011-02-21 KR KR1020127024535A patent/KR101776976B1/ko active Active
  • 2011-02-21 RS RS20191568A patent/RS59827B1/sr unknown
  • 2011-02-21 EP EP11745404.1A patent/EP2536399B1/en active Active
  • 2011-02-21 CN CN201180020149.0A patent/CN102970988B/zh active Active
  • 2011-02-21 US US13/580,102 patent/US9254336B2/en active Active
  • 2011-02-21 AU AU2011217794A patent/AU2011217794B2/en not_active Ceased
  • 2011-02-21 ES ES11745404T patent/ES2769629T3/es active Active
  • 2011-02-21 SI SI201131822T patent/SI2536399T1/sl unknown
  • 2011-02-21 HR HRP20192164TT patent/HRP20192164T1/hr unknown
  • 2011-02-21 MX MX2012009674A patent/MX2012009674A/es active IP Right Grant
  • 2011-02-21 WO PCT/US2011/025592 patent/WO2011103531A1/en not_active Ceased
  • 2011-02-21 BR BR112012020855A patent/BR112012020855B8/pt not_active IP Right Cessation
  • 2011-02-21 DK DK11745404.1T patent/DK2536399T3/da active
  • 2011-02-21 PE PE2012001335A patent/PE20130003A1/es not_active Application Discontinuation
  • 2011-02-21 NZ NZ601905A patent/NZ601905A/en not_active IP Right Cessation
  • 2011-02-21 JP JP2012554081A patent/JP5726915B2/ja active Active
  • 2011-02-21 PT PT117454041T patent/PT2536399T/pt unknown
  • 2011-02-21 CA CA2790401A patent/CA2790401C/en active Active
  • 2011-02-21 PL PL11745404T patent/PL2536399T3/pl unknown
  • 2011-02-21 UA UAA201210994A patent/UA115221C2/uk unknown
  • 2011-02-21 CN CN201610094308.6A patent/CN105664175B/zh active Active
  • 2011-02-21 SG SG2012060083A patent/SG183309A1/en unknown
  • 2011-02-21 LT LTEP11745404.1T patent/LT2536399T/lt unknown
  • 2011-02-21 PH PH1/2012/501664A patent/PH12012501664A1/en unknown
  • 2011-02-21 HU HUE11745404A patent/HUE047661T2/hu unknown
• 2012
  • 2012-08-14 IL IL221447A patent/IL221447A/en active IP Right Grant
  • 2012-08-17 ZA ZA2012/06215A patent/ZA201206215B/en unknown
  • 2012-08-20 GT GT201200244A patent/GT201200244A/es unknown
  • 2012-08-20 CL CL2012002306A patent/CL2012002306A1/es unknown
  • 2012-08-21 CR CR20120437A patent/CR20120437A/es unknown
  • 2012-08-21 CU CU2012000121A patent/CU20120121A7/es unknown
  • 2012-08-21 CO CO12141192A patent/CO6592111A2/es unknown
  • 2012-08-21 EC ECSP12012112 patent/ECSP12012112A/es unknown
• 2014
  • 2014-08-13 ZA ZA2014/05941A patent/ZA201405941B/en unknown
• 2016
  • 2016-08-11 PH PH12016501602A patent/PH12016501602A1/en unknown
• 2020
  • 2020-02-05 CY CY20201100113T patent/CY1122711T1/el unknown

Also Published As

Similar Documents